Guangzhou Ningjing Investment Management

Guangzhou Ningjing Investment Management is a Chinese investment and holding company focused on the biotechnology and life sciences sectors. Headquartered in Guangzhou, the firm is most notable as the founding and controlling shareholder of Bio-Thera Solutions, a leading developer of biosimilars and innovative biologics. Through its primary investments, the company oversees a robust pipeline of monoclonal antibodies and antibody-drug conjugates (ADCs) targeting oncology, autoimmune diseases, and cardiovascular conditions. The firm has successfully moved multiple biosimilars to the commercial stage, including treatments for rheumatoid arthritis and various cancers. Guangzhou Ningjing Investment plays a central role in the strategic financing and management of biopharmaceutical assets within the Pearl River Delta region. It operates as a key vehicle for the professional interests of Dr. Shengfeng Li, a major figure in the global biotechnology industry.